**Core Concept**
Aspirin is used in the treatment of myocardial infarction (MI) due to its antiplatelet effects, which help to prevent further clot formation and reduce the risk of secondary ischemic events.

**Why the Correct Answer is Right**
Aspirin inhibits the enzyme cyclooxygenase (COX), which is responsible for the production of thromboxane A2, a potent platelet aggregator. By blocking the production of thromboxane A2, aspirin reduces platelet activation and aggregation, thereby preventing the formation of new clots and reducing the risk of recurrent MI. This effect is particularly beneficial in the early stages of MI, when the risk of secondary ischemic events is highest.

**Why Each Wrong Option is Incorrect**
**Option A:**
This option is incorrect because while beta-blockers are used in the treatment of MI, they are primarily used to reduce the workload on the heart and decrease the risk of arrhythmias, rather than to prevent clot formation.

**Option B:**
This option is incorrect because while ACE inhibitors are used in the treatment of MI, they are primarily used to reduce the workload on the heart and decrease the risk of further cardiac damage, rather than to prevent clot formation.

**Option C:**
This option is incorrect because while anticoagulants are used in the treatment of MI, they are typically reserved for patients with a high risk of clotting, such as those with atrial fibrillation or a history of venous thromboembolism.

**Clinical Pearl / High-Yield Fact**
Aspirin should be administered as soon as possible in patients with suspected MI, ideally within the first 24-48 hours, to maximize its antiplatelet effects and reduce the risk of secondary ischemic events.

**Correct Answer:** D. Aspirin is the correct answer as it is used in the treatment of myocardial infarction to prevent further clot formation.